Vinci S.A. Stock
€119.60
Your prediction
Vinci S.A. Stock
Pros and Cons of Vinci S.A. in the next few years
Pros
Cons
Performance of Vinci S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vinci S.A. | 0.040% | 0.126% | -0.125% | 21.247% | 20.514% | 28.341% | 47.593% |
| Bouygues S.A. | -0.380% | 1.365% | 6.271% | 58.387% | 55.080% | 57.714% | 33.085% |
| Eiffage S.A. Inh. | -0.610% | 0.784% | 8.057% | 49.023% | 46.133% | 30.479% | 56.836% |
| Trimble Navigation | -1.410% | 2.169% | 4.246% | 1.455% | 3.350% | 53.941% | 27.927% |
Comments
News
Better Buy in 2026: Novo Nordisk or Intuitive Surgical?
Novo Nordisk (NYSE: NVO) and Intuitive Surgical (NASDAQ: ISRG) are both healthcare leaders, but they operate in different corners of this vast sector. The former markets pharmaceutical drugs, while
Should You Buy Shares of Intuitive Surgical in December?
There are many aspects of Intuitive Surgical's (NASDAQ: ISRG) business to appreciate. However, as famous investor Benjamin Graham one said, a good company can be a bad investment if you pay too much
Is Intuitive Surgical's Dominance Safe? 10 Years of Healthcare Upside
Over the past 25 years, Intuitive Surgical (NASDAQ: ISRG) has experienced significant success thanks to its pioneering use of robotics in surgery. The healthcare leader now stands as the undisputed


